4.7 Article

The Relationship of Epicardial Adipose Tissue and Cardiovascular Disease in Chronic Kidney Disease and Hemodialysis Patients

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/jcm11051308

Keywords

epicardial adipose tissue; cardiovascular morbidity and mortality; hemodialysis

Ask authors/readers for more resources

Cardiovascular diseases are the leading cause of death for patients with chronic kidney disease undergoing hemodialysis. Epicardial adipose tissue (EAT), a visceral fat depot of the heart, has been linked to coronary artery disease and is considered a novel cardiovascular risk factor, affecting morbidity and mortality in hemodialysis patients.
Cardiovascular diseases remain the most common cause of morbidity and mortality in chronic kidney disease patients undergoing hemodialysis. Epicardial adipose tissue (EAT), visceral fat depot of the heart, was found to be associated with coronary artery disease in cardiac and non-cardiac patients. Additionally, EAT has been proposed as a novel cardiovascular risk in the general population and in end-stage renal disease patients. It has also been shown that EAT, more than other subcutaneous adipose tissue deposits, acts as a highly active organ producing several bioactive adipokines, and proinflammatory and proatherogenic cytokines. Therefore, increased visceral adiposity is associated with proinflammatory activity, impaired insulin sensitivity, increased risk of atherosclerosis, and high morbidity and mortality in hemodialysis patients. In the present review, we aimed to demonstrate the role of EAT in the pathophysiological mechanisms of increased cardiovascular morbidity and mortality in hemodialysis patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available